A record of what Narendra Solanki said publicly, with the source. Not advice.
Pending — not yet graded
“Narendra Solanki is constructive on the healthcare sector, particularly hospitals, and anticipates a gradual turnaround in pharma manufacturing. He identifies upcoming GLP-1 patent expiries in early 2026 in major markets like India and Brazil, alongside opportunities in complex generics, as key catalysts for the sector.”
Nifty Healthcare IndexBullishCalled 07 Jan 2026
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Narendra Solanki’s full track record